You are here
FDA Approves Generic Diprolene Cream
December 12, 2003
Bnei Brak, Israel -- December 9, 2003 -- On December 9, 2003 Agis Industries, concomitantly with two other generic companies, received from the FDA immediate approval to market the generic drug, Augmented Betamethasone Dipropionate Cream 0.05%.
Augmented Betamethasone Dipropionate Cream 0.05% is the AB-Rated equivalent of Schering – Ploughés Diprolene® AF Cream, a topical corticosteroid product for treatment of inflammatory skin conditions.
Source: Agis Industries
Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs
Acasti reports disappointing results for a second Omega-3-based drug
Declining lung cancer mortality helped fuel the progress